ODTX ODTX MDA5 — Business Combination Contingent Consideration Liability Measurement Input

Similar metrics at other companies

WEXBusiness Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1

$700K-12.5%

CVLTBusiness Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1

$0—

RYANBusiness Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1

$27.29M+294%

APOAsset Management — Contingent consideration obligations, measurement input

25%0.0pp

RGTIBusiness Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1

$0-100%

IRMBusiness Combination, Contingent Consideration Arrangements, Gain (Loss) On Remeasurement Of Contingent Consideration, Liability

-$17.84M—

Questions, answered.

What is ODTX's MDA5 — business combination contingent consideration liability measurement input?

ODTX (ODTX) reported MDA5 — business combination contingent consideration liability measurement input of 3,500% in Q1 2026.

What does MDA5 — business combination contingent consideration liability measurement input mean?

This metric represents the key valuation inputs, such as probability-weighted clinical milestones or revenue projections, used to determine the fair value of contingent consideration liabilities associated with the acquisition of the MDA5 program. It reflects the financial obligation owed to former shareholders or partners contingent upon the successful development, regulatory approval, or commercialization of the MDA5-targeted therapeutic. Changes in these inputs directly impact the company's balance sheet and reported earnings through periodic fair value adjustments.